126 related articles for article (PubMed ID: 31114998)
1. MiR-376a functions as tumor suppressor by targeting SGK3 in renal cell carcinoma.
Fan XR; Zhang ZY; Wang RH; Li Y; Mao QZ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3726-3732. PubMed ID: 31114998
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
Wang C; Cai L; Liu J; Wang G; Li H; Wang X; Xu W; Ren M; Feng L; Liu P; Zhang C
Cell Physiol Biochem; 2017; 43(6):2405-2419. PubMed ID: 29073630
[TBL] [Abstract][Full Text] [Related]
5. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
[TBL] [Abstract][Full Text] [Related]
6. miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression.
Jiang K; Sun F; Zhu J; Luo G; Ban Y; Zhang P
Mol Genet Genomic Med; 2019 Aug; 7(8):e833. PubMed ID: 31250570
[TBL] [Abstract][Full Text] [Related]
7. miR-206 inhibits renal cell cancer growth by targeting GAK.
Wei C; Wang S; Ye ZQ; Chen ZQ
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 functions as an oncogene and promotes cell proliferation and invasion via TIMP3 in renal cancer.
Chen J; Gu Y; Shen W
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4566-4576. PubMed ID: 29131259
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑613 inhibits proliferation and invasion of renal cell carcinoma cells through targeting FZD7.
Song H; Nan Y; Wang X; Zhang G; Zong S; Kong X
Mol Med Rep; 2017 Oct; 16(4):4279-4286. PubMed ID: 29067457
[TBL] [Abstract][Full Text] [Related]
10. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
[TBL] [Abstract][Full Text] [Related]
11. An increased level of MiR-222-3p is associated with TMP2 suppression, ERK activation and is associated with metastasis and a poor prognosis in renal clear cell carcinoma.
Lyu J; Zhu Y; Zhang Q
Cancer Biomark; 2020; 28(2):141-149. PubMed ID: 32116235
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
Li G; Chong T; Xiang X; Yang J; Li H
Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
[TBL] [Abstract][Full Text] [Related]
13. Expression and functional role of miR-29b in renal cell carcinoma.
Xu Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Tong Y
Int J Clin Exp Pathol; 2015; 8(11):14161-70. PubMed ID: 26823729
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-22 functions as a tumor suppressor by targeting SIRT1 in renal cell carcinoma.
Zhang S; Zhang D; Yi C; Wang Y; Wang H; Wang J
Oncol Rep; 2016 Jan; 35(1):559-67. PubMed ID: 26499759
[TBL] [Abstract][Full Text] [Related]
15. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
17. Mir-451 Correlates with Prognosis of Renal Cell Carcinoma Patients and Inhibits Cellular Proliferation of Renal Cell Carcinoma.
Zhu S; Huang Y; Su X
Med Sci Monit; 2016 Jan; 22():183-90. PubMed ID: 26779781
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP.
Liu S; Yang Y; Wang W; Pan X
J Cell Biochem; 2018 Dec; 119(12):9694-9706. PubMed ID: 30132963
[TBL] [Abstract][Full Text] [Related]
19. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
[TBL] [Abstract][Full Text] [Related]
20. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway.
Chen Q; Liu T; Bao Y; Zhao T; Wang J; Wang H; Wang A; Gan X; Wu Z; Wang L
Cancer Lett; 2020 Jan; 469():68-77. PubMed ID: 31629934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
